Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice
Open Access
- 4 October 2012
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 27 (1), 187-198
- https://doi.org/10.1096/fj.12-208660
Abstract
The accumulation of aggregated amyloid-β (Aβ) in amyloid plaques is a neuropathological hallmark of Alzheimer's disease (AD). Reactive astrocytes are intimately associated with amyloid plaques; however, their role in AD pathogenesis is unclear. We deleted the genes encoding two intermediate filament proteins required for astrocyte activation—glial fibrillary acid protein (Gfap) and vimentin (Vim)—in transgenic mice expressing mutant human amyloid precursor protein and presenilin-1 (APP/PS1). The gene deletions increased amyloid plaque load: APP/PS1 Gfap–/– Vim–/– mice had twice the plaque load of APP/PS1 Gfap+/+ Vim+/+ mice at 8 and 12 mo of age. APP expression and soluble and interstitial fluid Aβ levels were unchanged, suggesting that the deletions had no effect on APP processing or Aβ generation. Astrocyte morphology was markedly altered by the deletions: wild-type astrocytes had hypertrophied processes that surrounded and infiltrated plaques, whereas Gfap–/– Vim–/– astrocytes had little process hypertrophy and lacked contact with adjacent plaques. Moreover, Gfap and Vim gene deletion resulted in a marked increase in dystrophic neurites (2- to 3-fold higher than APP/PS1 Gfap+/+ Vim+/+ mice), even after normalization for amyloid load. These results suggest that astrocyte activation limits plaque growth and attenuates plaque-related dystrophic neurites. These activities may require intimate contact between astrocyte and plaque.—Kraft, A. W., Hu, X., Yoon, H., Yan, P., Xiao, Q., Wang, Y., Gil, S. C., Brown, J., Wilhelmsson, U., Restivo, J. L., Cirrito, J. R., Holtzman, D. M., Kim, J., Pekny, M., Lee, J.-M. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 27, 187–198 (2013). www.fasebj.orgKeywords
Funding Information
- National Institutes of Health (R01 NS48283, R01 NS67905, P01 NS32636, R37 AG13956, P30NS69329)
- Medicinska Forskningsrådet (11548)
This publication has 68 references indexed in Scilit:
- IFN-γ-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filamentsJournal of Neuroinflammation, 2012
- Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A2 activation in astrocytes and cerebral endothelial cellsNeuroscience, 2011
- Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ ClearanceNeuron, 2009
- Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid depositionThe FASEB Journal, 2009
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008
- Attenuated Glial Reactions and Photoreceptor Degeneration after Retinal Detachment in Mice Deficient in Glial Fibrillary Acidic Protein and VimentinInvestigative Ophthalmology & Visual Science, 2007
- Transgenic mice overexpressing reticulon 3 develop neuritic abnormalitiesThe EMBO Journal, 2007
- Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injuryProceedings of the National Academy of Sciences of the United States of America, 2006
- Astrocyte activation and reactive gliosisGlia, 2005